Literature DB >> 10385435

Localization of bradykinin B2 receptors in the endometrium and myometrium of rat uterus and the effects of estrogen and progesterone.

C Murone1, S Y Chai, W Müller-Esterl, F A Mendelsohn, J Clements.   

Abstract

In the uterus, bradykinin is a potent inducer of smooth muscle contraction, which is mediated by the bradykinin B2 receptor subtype. However, little is known about the distribution or regulation of this receptor in this tissue. The aim of this study was to localize the B2 receptor in the uterus and determine whether the levels of this receptor were altered during the estrous cycle and modulated by estrogen and/or progesterone in ovariectomized rats. At diestrus, uterine B2 receptors were localized to both the circular and longitudinal smooth muscle layers of the myometrium, the endometrial stroma, the glandular epithelium, and the layer subjacent to the luminal epithelium. B2 receptor levels in both myometrium and endometrium were lowest during early proestrus, when estrogen levels are low, whereas myometrial B2 receptor protein and messenger RNA levels were highest during late proestrous, when estrogen levels peak. Similar findings were observed for the estrogen-supplemented group after ovariectomy, with progesterone appearing to inhibit the estrogen-induced rise in bradykinin B2 receptor density in estrogen/progesterone-treated animals. Using in vitro receptor autoradiography employing the specific B2 receptor antagonist analog, HPP-HOE140, immunostaining with specific antipeptide antibodies generated against the B2 receptor, and in situ hybridization using a specific bradykinin B2 receptor riboprobe, our findings show a discrete distribution of the bradykinin B2 receptor throughout the different layers of the uterus and suggest that bradykinin B2 receptor levels in the rat uterus are regulated by estrogen, and possibly progesterone, in both myometrium and endometrium.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10385435     DOI: 10.1210/endo.140.7.6871

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  3 in total

Review 1.  Considerations in the management of hereditary angioedema due to C1-INH deficiency in women of childbearing age.

Authors:  Florence Ida Hsu; William Lumry; Marc Riedl; Raffi Tachdjian
Journal:  Allergy Asthma Clin Immunol       Date:  2022-07-13       Impact factor: 3.373

2.  Hormone replacement therapy reduces lipid oxidation directly at the arterial wall: A possible link to estrogens' cardioprotective effect through atherosclerosis prevention.

Authors:  Carlos Gómez Escalante; Silvia Quesada Mora; Laura Navarro Bolaños
Journal:  J Midlife Health       Date:  2017 Jan-Mar

3.  Conflicting Nongenomic Effects of Progesterone in the Myometrium of Pregnant Rats.

Authors:  Katsuhiko Yasuda; Aya Yoshida; Hidetaka Okada
Journal:  Int J Mol Sci       Date:  2021-02-22       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.